Today, we have notified the FDA that a serious adverse event occurred at one of our plasma donation centers.

Our staff provided emergency care onsite and the donor was taken to the local hospital.

Our thoughts are with the donor and their family to whom we have offered support.

The safety of every donor is our utmost priority, and we take any adverse event very seriously.  Without donors, we can’t make the lifesaving therapies patients need.  We are conducting thorough investigations into the incident and are working with the relevant authorities.

Media Contact:

James Freeman
CSL Behring
Mobile: +1 484.832.9045
Email: james.freeman@cslbehring.com